VBI Vaccines (VBIV) PT Raised to $8 at Oppenheimer Following Positive Updates in Glioblastoma
Tweet Send to a Friend
Oppenheimer analyst Leland Gershell raised the price target on VBI Vaccines (NASDAQ: VBIV) to $8.00 (from $5.00) while maintaining an ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
